Astrocyte-targeted CNS Therapies
CNS Trauma, Neurodegenerative Diseases, Brain Edema, Glioma
Discovery/Pre-clinicalActive
Key Facts
Indication
CNS Trauma, Neurodegenerative Diseases, Brain Edema, Glioma
Phase
Discovery/Pre-clinical
Status
Active
Company
About Celica Biomedical
Celica Biomedical is a privately held, pre-revenue Slovenian research institute founded in 2000, specializing in neuroscience (particularly astrocyte biology) and oncology immunotherapies. The company leverages a deep scientific foundation in regulated exocytosis and cell physiology to develop novel treatment strategies for CNS disorders and cancer vaccines. It operates a quality-managed laboratory, secures public research funding, and collaborates internationally, positioning itself to bridge the gap between academic discovery and clinical application.
View full company profile